Skip to main content

Table 2 Sociodemographic and medical characteristics of study participants by group

From: The prevalence of metabolic syndrome in patients receiving antipsychotics in Qatar: a cross sectional comparative study

Variables

Antipsychotics group (n = 112)

Control group (n = 114)

Age (mean ± SD)

35.73 ± 10.28

35.73 ± 8.16

Gender n (%)

 Male

 Female

73 (65.2%)

39 (34.8%)

69 (60.5%)

45 (39.5%)

Ethnicity n (%)

 Qataris and Arabs

 Non-Arabs

79 (71.2%)*

32 (28.8%)

52 (45.6%)

62 (54.4%)**

Marital status n (%)

 Married

 Single

 Divorced

43 (38.4%)

57 (50.9%)*

12 (10.7%)*

83 (72.8%)**

30 (26.3%)

1 (0.9%)

Degree n (%)

 None

 School

 Vocational

 College/graduate

4 (3.6%)

72 (64.3%)*

7 (6.3%)

28 (25.0%)

4 (3.5%)

45 (39.5%)

15 (13.2%)

49 (43.0%)**

Employment n (%)

 Employed

 Not employed

 Other (student, retired, etc.)

41 (36.6%)

62 (55.4%)*

9 (8%)

103 (90.4%)**

9 (7.8%)

2 (1.8%)

Smoking/current n (%)

 Yes

 No

40 (36.7%)*

69 (63.3%)

18 (18%)

82 (82%)**

Smoking/ever n (%)

 Yes

 No

52 (47.3%)*

58 (52.7%)

26 (22.8%)

88 (77.2%)**

History of Diabetes n (%)

 Yes

 No

9 (8.2%)

101 (91.8%)

8 (7.3%)

101 (92.7%)

Family history of diabetes n (%)

 Yes

 No

74 (66.1%)

38 (33.9%)

74 (64.9%)

40 (35.1%)

Body mass index (BMI)

(mean ± SD)

29.12 ± 6.95

27.74 ± 5.05

  1. *Higher than the control group; **Higher than the antipsychotics group (p < 0.05)